Smith & Nephew Plc Director/PDMR Shareholding (0505Z)
19 May 2021 - 2:15AM
UK Regulatory
TIDMSN.
RNS Number : 0505Z
Smith & Nephew Plc
18 May 2021
SMITH & NEPHEW PLC
18 May 2021
NOTIFICATION AND PUBLIC DISCLOSURE IN ACCORDANCE WITH THE
REQUIREMENTS OF THE EU MARKET ABUSE REGULATION OF TRANSACTIONS BY
PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES ("PDMR") AND
PERSONS CLOSELY ASSOCIATED WITH THEM.
Reason for the notification
Initial notification Initial notification
/Amendment
--------------------------------------------------
Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
Name Smith & Nephew plc
--------------------------------------------------
LEI 213800ZTMDN8S67S1H61
--------------------------------------------------
Details of the transaction(s): section to be repeated for (i)
each type of instrument; (ii) each type of transaction; (iii)
each date; and (iv) each place where transactions have been conducted
Description of the financial Smith & Nephew plc SPON ADR American Depositary
instrument, type of Shares (ADS)
instrument
--------------------------------------------------
Identification code ISIN: US83175M2052
--------------------------------------------------
Nature of the transaction PDMR is a participant of the Company's Employee
Stock Purchase Plan, which purchased American
Depository Shares through the Company's Dividend
Re-Investment Plan following the 2020 final
dividend payment on 12 May 2021.
--------------------------------------------------
Date of Transaction 2021 - 05 - 14
--------------------------------------------------
Place of Transaction New York Stock Exchange
--------------------------------------------------
Total Ordinary
Share Holding
Total Ordinary as a % of
Share Holding the Company's
following ISC following
Director Price Aggregated the transaction the transaction
Name (Position) / PDMR ($) Volume information * *
Bradley
Cannon 77,339.58864
(President (including
Sports Medicine N/A Single 2,123.73810
& ENT) PDMR 42.9981 22.0926 Transaction in ADS') 0.00874%
---------- -------- --------- ------------- ----------------- -----------------
Catheryn
O'Rourke 82,222.87749
(Chief Legal (including
& Compliance N/A Single 5,879.41935
Officer) PDMR 42.9981 61.16201 Transaction in ADS') 0.00929%
---------- -------- --------- ------------- ----------------- -----------------
* including those held by Persons Closely Associated with the
Director/PDMR. All figures in these columns are stated to 5 decimal
places where applicable.
Vickie Reuben
Deputy Company Secretary
Smith & Nephew plc
Tel: +44 (0)1923 477410
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
DSHFLFIREEITLIL
(END) Dow Jones Newswires
May 18, 2021 12:15 ET (16:15 GMT)
Smith & Nephew (LSE:SN.)
Historical Stock Chart
From Apr 2024 to May 2024
Smith & Nephew (LSE:SN.)
Historical Stock Chart
From May 2023 to May 2024